HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status
HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended June 30, 2024
HUTCHMED: Filing of Form F-3
HUTCHMED: Blocklisting Six Monthly Return
HUTCHMED: Total Voting Rights
HUTCHMED: DATE OF BOARD MEETING AND ANNOUNCEMENT OF 2024 INTERIM RESULTS
HUTCHMED: VOLUNTARY ANNOUNCEMENT - Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024
HUTCHMED: HUTCHMED Announces European Commission Approval for FRUZAQLA (fruquintinib) Received by Takeda
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China
HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended May 31, 2024
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
HUTCHMED: Total Voting Rights
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
HUTCHMED: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
HUTCHMED: HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naive Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
HUTCHMED: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
No Data